FRUSCIO, ROBERT
 Distribuzione geografica
Continente #
NA - Nord America 33.633
AS - Asia 19.650
EU - Europa 14.745
SA - Sud America 2.783
Continente sconosciuto - Info sul continente non disponibili 1.401
AF - Africa 459
OC - Oceania 73
Totale 72.744
Nazione #
US - Stati Uniti d'America 31.887
SG - Singapore 6.490
IT - Italia 4.934
CN - Cina 3.908
VN - Vietnam 2.929
HK - Hong Kong 2.515
RU - Federazione Russa 2.027
BR - Brasile 1.981
DE - Germania 1.336
CA - Canada 1.288
IE - Irlanda 1.180
SE - Svezia 1.061
BD - Bangladesh 1.000
GB - Regno Unito 813
FR - Francia 772
UA - Ucraina 711
IN - India 542
FI - Finlandia 387
ID - Indonesia 381
KR - Corea 311
TR - Turchia 302
ES - Italia 293
NL - Olanda 264
AR - Argentina 255
JP - Giappone 216
AT - Austria 210
MX - Messico 207
IQ - Iraq 194
CO - Colombia 156
ZA - Sudafrica 138
SA - Arabia Saudita 118
PL - Polonia 115
PH - Filippine 111
EC - Ecuador 105
PK - Pakistan 105
DK - Danimarca 92
CH - Svizzera 85
VE - Venezuela 81
BE - Belgio 73
CL - Cile 73
CZ - Repubblica Ceca 66
MA - Marocco 63
AU - Australia 62
EG - Egitto 59
JM - Giamaica 56
TH - Thailandia 53
MY - Malesia 52
UZ - Uzbekistan 52
PE - Perù 50
AE - Emirati Arabi Uniti 49
CR - Costa Rica 46
GR - Grecia 46
RO - Romania 43
KE - Kenya 42
PT - Portogallo 40
PY - Paraguay 39
TN - Tunisia 36
IR - Iran 33
SK - Slovacchia (Repubblica Slovacca) 31
HN - Honduras 27
IL - Israele 27
JO - Giordania 27
NP - Nepal 27
UY - Uruguay 27
LT - Lituania 25
KZ - Kazakistan 24
ET - Etiopia 23
BG - Bulgaria 22
SV - El Salvador 22
DZ - Algeria 21
PS - Palestinian Territory 20
TT - Trinidad e Tobago 20
LB - Libano 19
RS - Serbia 18
TW - Taiwan 18
AL - Albania 17
AZ - Azerbaigian 17
GT - Guatemala 16
NI - Nicaragua 16
OM - Oman 16
EE - Estonia 15
EU - Europa 15
LV - Lettonia 15
SN - Senegal 15
HU - Ungheria 11
CI - Costa d'Avorio 10
KH - Cambogia 10
KW - Kuwait 10
LK - Sri Lanka 10
MD - Moldavia 10
BO - Bolivia 9
NG - Nigeria 9
A2 - ???statistics.table.value.countryCode.A2??? 8
BA - Bosnia-Erzegovina 8
DO - Repubblica Dominicana 8
KG - Kirghizistan 8
AO - Angola 7
BB - Barbados 7
BH - Bahrain 7
GE - Georgia 7
Totale 71.212
Città #
Singapore 3.682
Ashburn 3.463
Ann Arbor 3.294
Hong Kong 2.449
San Jose 1.993
Woodbridge 1.571
Fairfield 1.494
Milan 1.298
Houston 1.138
Dublin 1.119
Chandler 950
Ho Chi Minh City 886
New York 831
Wilmington 828
Toronto 827
Santa Clara 746
Hanoi 717
Jacksonville 705
Frankfurt am Main 678
Seattle 670
Council Bluffs 664
Los Angeles 641
Hefei 604
Dallas 585
Chicago 551
Cambridge 521
Dearborn 492
Rome 449
The Dalles 441
Beijing 434
Princeton 429
Boardman 293
Seoul 282
Lauterbourg 272
Jakarta 267
Buffalo 237
Hangzhou 227
Moscow 219
Nanjing 212
Shanghai 201
Lawrence 194
Columbus 191
São Paulo 177
Altamura 170
Phoenix 168
Helsinki 164
Vienna 145
Tokyo 131
San Diego 125
Atlanta 124
London 120
Nuremberg 116
Lachine 112
Figino 110
Da Nang 108
Brooklyn 107
Guangzhou 106
Orem 98
Haiphong 91
Montreal 91
Denver 90
Munich 90
Naples 89
Lissone 88
Nanchang 81
Turin 79
Baghdad 77
Chennai 74
Washington 74
Istanbul 73
Elk Grove Village 69
San Francisco 69
Johannesburg 68
Ottawa 68
Warsaw 68
Amsterdam 64
Rio de Janeiro 64
Salt Lake City 64
Andover 62
Boston 61
Lappeenranta 61
Bologna 58
Shenyang 57
Dong Ket 56
Florence 54
Philadelphia 54
Fremont 53
Changsha 52
Baltimore 50
Brno 50
Kent 50
Manchester 50
Brasília 48
Biên Hòa 47
Mexico City 47
Dhaka 46
Charlotte 45
Hải Dương 45
Jinan 45
Tampa 45
Totale 42.493
Nome #
Association between multimorbidity and postoperative mortality in patients undergoing major surgery: a prospective study in 29 countries across Europe 1.112
Predicting the risk of malignancy in adnexal masses based on the Simple Rules from the International Ovarian Tumor Analysis group 1.048
Reducing the environmental impact of surgery on a global scale: systematic review and co-prioritization with healthcare workers in 132 countries 625
Management and outcome of colorectal cancer during pregnancy: report of 41 cases 561
Oncologic and fertility impact of surgical approach for borderline ovarian tumours treated with fertility sparing surgery 560
Radiomics of the primary tumour as a tool to improve 18F-FDG-PET sensitivity in detecting nodal metastases in endometrial cancer 502
Multisite analysis of high-grade serous epithelial ovarian cancers identifies genomic regions of focal and recurrent copy number alteration in 3q26.2 and 8q24.3 493
Bilateral Oophorectomy and All-Cause Mortality in Women With BRCA1 and BRCA2 Sequence Variations 478
Role of 18F-fluoro-2-deoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) in malignant ovarian germ cell tumors: a single-center experience with long term follow-up 478
Combining positron emission tomography/computed tomography, radiomics, and sentinel lymph node mapping for nodal staging of endometrial cancer patients 472
Ovarian function, fertility, and menopause occurrence after fertility-sparing surgery and chemotherapy for ovarian neoplasms 455
Prevalence of human papillomavirus (HPV) and other sexually transmitted infections (STIS) among italian women referred for a colposcopy 423
Machine learning risk prediction of mortality for patients undergoing surgery with perioperative SARS-CoV-2: The COVIDSurg mortality score 416
Staging of High-Risk Endometrial Cancer With PET/CT and Sentinel Lymph Node Mapping 413
Detection of TP53 Clonal Variants in Papanicolaou Test Samples Collected up to 6 Years Prior to High-Grade Serous Epithelial Ovarian Cancer Diagnosis 407
Evaluating the risk of ovarian cancer before surgery using the ADNEX model to differentiate between benign, borderline, early and advanced stage invasive, and secondary metastatic tumours: prospective multicentre diagnostic study 403
Histologic and metabolic assessment in a cohort of patients with genital prolapse: Preoperative stage and recurrence investigations 388
18F-FDG PET/CT can predict nodal metastases but not recurrence in early stage uterine cervical cancer 386
Early-stage clear cell ovarian cancer compared to high-grade histological subtypes: An outcome exploratory analysis in two oncology centers 386
Helmet CPAP to treat hypoxic pneumonia outside the ICU: an observational study during the COVID-19 outbreak 384
Long-term results of fertility-sparing treatment compared with standard radical surgery for early-stage epithelial ovarian cancer 373
Two ultrastaging protocols for the detection of lymph node metastases in early-stage cervical and endometrial cancers 370
Iliococcygeus fixation or abdominal sacral colpopexy for the treatment of vaginal vault prolapse: a retrospective cohort study 363
Tailoring systematic lymphadenectomy in high-risk clinical early stage endometrial cancer: the role of 18F-FDG PET/CT 359
Clinical and ultrasound characteristics of the microcystic elongated and fragmented (MELF) pattern in endometrial cancer according to the International Endometrial Tumor Analysis (IETA) criteria 354
Randomized phase III clinical trial evaluating weekly cisplatin for advanced epithelial ovarian cancer 351
Characteristics of patients with cervical cancer during pregnancy: A multicenter matched cohort study. An initiative from the International Network on Cancer, Infertility and Pregnancy 350
The paradigm shift in advanced ovarian cancer: Outcomes of extensive primary cytoreductive surgery. A single-center retrospective analysis 349
Preoperative staging of cervical cancer: is 18-FDG-PET/CT really effective in patients with early stage disease? 348
Impact of postoperative cardiovascular complications on 30-day mortality after major abdominal surgery: an international prospective cohort study 345
Genome-wide Copy-number Alterations in Circulating Tumor DNA as a Novel Biomarker for Patients with High-grade Serous Ovarian Cancer 344
OC13. 02: Reproducibility of IETA terms in describing endometrial pathology 340
Analysis of gene expression in early-stage ovarian cancer 336
Preoperative 18F-FDG PET/CT in the management of advanced epithelial ovarian cancer 336
Incidence of peritoneal cancer after oophorectomy among BRCA1 and BRCA2 mutation carriers 335
LncRNAs as novel indicators of patients' prognosis in stage i epithelial ovarian cancer: A retrospective and multicentric study 335
Better anatomical and cosmetic results using tunneled lotus petal flap for plastic reconstruction after demolitive surgery for vulvar malignancyc 334
The contribution of a collagen-fibrin patch (Tachosil) to prevent the postoperative lymphatic complications after groin lymphadenectomy: A double institution observational study 331
Treatment of simple and complex endometrial non-atypical hyperplasia with natural progesterone: response rate to different doses 330
Elective surgery system strengthening: development, measurement, and validation of the surgical preparedness index across 1632 hospitals in 119 countries 329
A prognostic regulatory pathway in stage I epithelial ovarian cancer: New hints for the poor prognosis assessment 328
Ovarian carcinoma tumor-initiating cells have a mesenchymal phenotype 319
Detection of nodal metastases by 18F-FDG PET/CT in apparent early stage ovarian cancer: a prospective study 319
Conservative management of early-stage epithelial ovarian cancer: results of a large retrospective series 315
Risk of complications in patients with conservatively managed ovarian tumours (IOTA5): a 2-year interim analysis of a multicentre, prospective, cohort study 313
Is there any therapeutic role of pelvic and para-aortic lymphadenectomy in apparent early stage epithelial ovarian cancer? 313
Tubal histopathological abnormalities in BRCA1/2 mutation carriers undergoing prophylactic salpingo-oophorectomy: a case-control study 313
Child development at 6 years after maternal cancer diagnosis and treatment during pregnancy 312
Delaying surgery for patients with a previous SARS-CoV-2 infection 310
Low-Volume Metastases in Cervical Cancer: Does Size Matter? 304
Diagnosis and management of isolated serous tubal intraepithelial carcinoma: A qualitative focus group study 301
GestaTIonal TrophoblAstic NeoplasIa Ultrasound assessMent: TITANIUM study 298
Real-Time Single-Walled Carbon Nanotube-Based Fluorescence Imaging Improves Survival after Debulking Surgery in an Ovarian Cancer Model 296
Ovarian Carcinoma Xenografts–Drug Response and Molecular Characterization 293
Ultrasound characteristics of endometrial cancer as defined by the International Endometrial Tumor Analysis (IETA) consensus nomenclature - A prospective multicenter study 293
Synchronous early-stage endometrial and ovarian cancer 291
Gynecologic cancers in pregnancy: Guidelines based on a third international consensus meeting 288
Outcome of patients with stage I immature teratoma after surveillance or adjuvant chemotherapy 287
Simple ultrasound rules to distinguish between benign and malignant adnexal masses before surgery: prospective validation by IOTA group 287
Fertility outcomes in stage I ovarian immature teratomas 286
Association between miR-200c and the survival of patients with stage I epithelial ovarian cancer: a retrospective study of two independent tumour tissue collections 286
The role of pelvic and aortic lymphadenectomy at second look surgery in apparent early stage ovarian cancer after inadequate surgical staging followed by adjuvant chemotherapy 284
Maximum standardized uptake value (SUVmax) as prognostic factor for surgical cytoreduction and response to adjuvant chemotherapy in women submitted to 18F-FDG PET/CT for staging of advanced epithelial ovarian cancer (aEOC) 284
Association between physical activity and menstrual cycle disorders in young athletes 283
925pmatched cohort study on patients with cervical cancer diagnosed during pregnancy 283
Efficacy of a Diode Vaginal Laser in the Treatment of the Genitourinary Syndrome of Menopause 282
Accuracy of Human Papillomavirus (HPV) Testing on Urine and Vaginal Self-Samples Compared to Clinician-Collected Cervical Sample in Women Referred to Colposcopy 278
Evaluation of Human Papilloma Virus (HPV) Genotyping and Viral Load Determination as Diagnostic Biomarkers of Cervical Cancer Risk 277
Systematic lymphadenectomy in ovarian cancer at second-look surgery: a randomised clinical trial 277
Ascites interferes with the activity of lurbinectedin and trabectedin: Potential role of their binding to alpha 1-acid glycoprotein 277
Profiling cancer gene mutations in longitudinal epithelial ovarian cancer biopsies by targeted next-generation sequencing: a retrospective study 275
601: Cisplatin response in a panel of patient-derived ovarian carcinoma xenografts: roles of epithelial mesenchymal transition and DNA repair 275
Delivery delay with neoadjuvant chemotherapy for cervical cancer patients during pregnancy: A series of nine cases and literature review 271
Regional and temporal heterogeneity of epithelial ovarian cancer tumor biopsies: implications for therapeutic strategies 271
An exploration of body image distress in women who underwent a prophylactic bilateral salpingo-oophorectomy (PBSO) 271
Molecular Detection of Human Papillomavirus (HPV) and Other Sexually Transmitted Pathogens in Cervical and Self-Collected Specimens 270
The use of TachoSil for the prevention of postoperative complications after groin dissection in cases of gynecologic malignancy 268
Heterotypic CAF-tumor spheroids promote early peritoneal metastatis of ovarian cancer 267
Resistance to platinum-based chemotherapy is associated with epithelial to mesenchymal transition in epithelial ovarian cancer 266
Benefit from maintenance with PARP inhibitor in newly diagnosed ovarian cancer according to BRCA1/2 mutation type and site: a multicenter real-world study 265
A phase II clinical trial of topotecan and carboplatin in patients with newly diagnosed advanced epithelial ovarian cancer 265
Clinical utility of risk modelsto refer patients with adnexal masses to specialized oncology care: Multicenter external validation using decision curve analysis 263
Adjuvant sequential chemo and radiotherapy improves the oncological outcome in high risk endometrial cancer 262
Long-term follow-up of patients with an isolated ovarian recurrence after conservative treatment of epithelial ovarian cancer: review of the results of an international multicenter study comprising 545 patients 262
Expression profiles of PRKG1, SDF2L1 and PPP1R12A are predictive and prognostic factors for therapy response and survival in high-grade serous ovarian cancer 261
Evaluation of BD Onclarity™ HPV Assay on Self-Collected Vaginal and First-Void Urine Samples as Compared to Clinician-Collected Cervical Samples: A Pilot Study 259
Borderline ovarian cancer 259
Evaluation of two alternative non-alcohol-based media for the suspension of self-collected vaginal swabs for HPV testing in cervical cancer screening 258
Platinum sensitivity and DNA repair in a recently established panel of patient-derived ovarian carcinoma xenografts 257
PRL-3 phosphatase is implicated in ovarian cancer growth 256
Oncological management and obstetric and neonatal outcomes for women diagnosed with cancer during pregnancy: a 20-year international cohort study of 1170 patients 256
A phase II randomised clinical trial comparing cisplatin, paclitaxel and ifosfamide with cisplatin, paclitaxel and epirubicin in newly diagnosed advanced epithelial ovarian cancer: long-term survival analysis 252
Expression of DNA repair genes in ovarian cancer samples: biological and clinical considerations 251
Patient-derived ovarian tumor xenografts recapitulate human clinicopathology and genetic alterations 250
Managing Ovarian tumors during pregnancy 250
Copy number alterations in stage I epithelial ovarian cancer highlight three genomic patterns associated with prognosis 250
Oophorectomy and risk of contralateral breast cancer among BRCA1 and BRCA2 mutation carriers 248
Imaging in gynecological disease (14): clinical and ultrasound characteristics of ovarian clear cell carcinoma 247
DNA-damage response gene polymorphisms and therapeutic outcomes in ovarian cancer 246
Management of primary and recurrent Bartholin’s gland carcinoma: A systematic review on behalf of MITO Rare Cancer Group 245
Totale 33.975
Categoria #
all - tutte 237.748
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 237.748


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.987 0 0 0 250 149 252 121 147 139 254 218 457
2022/20234.327 475 1.202 357 329 253 688 118 247 326 44 162 126
2023/20244.313 127 142 238 269 503 948 776 184 352 133 123 518
2024/202511.485 583 1.228 523 532 901 610 604 537 1.227 1.683 1.027 2.030
2025/202628.226 3.093 2.037 1.923 2.581 2.816 1.364 3.485 1.323 2.085 2.479 2.218 2.822
2026/20277.185 1.493 1.738 3.290 664 0 0 0 0 0 0 0 0
Totale 72.744